Who are NunaBio - company's investors?

NunaBio - company's investors include Ascension, EMV Capital, Martlet Capital, Maven Capital Partners, Northstar Ventures.

Where is NunaBio - company headquartered?

NunaBio - company is headquartered in Newcastle upon Tyne, GB.

NunaBio - company

Newcastle upon Tyne, GB · Founded 2021 · 5 known investors

Find your way into NunaBio - company

Paths you didn't know you had: your email and LinkedIn already hold routes to the NunaBio - company team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

NunaBio manufactures high-complexity DNA constructs from challenging sequences up to production-scale volumes using a modular, cell-free "DNA micro-foundry" platform. It provides software-orchestrated, distributed DNA manufacturing infrastructure for producing complex DNA without process redevelopment.

Biotech Deep Tech Hardware New Materials

Investors · 5

Ascensionlisted by AscensionLondon · $190K – $1.1M

How we know: Ascension's portfolio page · Not right? Tell us

EMV Capitallisted by EMV CapitalLondon

How we know: EMV Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Martlet Capitallisted by Martlet CapitalCambridge · $317.5K

Maven Capital Partnerslisted by Maven Capital PartnersGlasgow · $32K – $25M

How we know: Maven Capital Partners's portfolio page · Not right? Tell us

Northstar Ventureslisted by Northstar VenturesNewcastle upon Tyne · $38.1K – $1.3M

How we know: Northstar Ventures's portfolio page · a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Related companies · 4

Nosis BioNosis develops a platform for receptor-targeted delivery of RNA therapeutics to specific cell types, addressing a key bottleneck in RNA drug development. The company aims to reduce the cost and timeline of bringing new RNA medicines to market.

Nuvation BioNuvation Bio is a global oncology company that develops novel cancer therapies through its own drug discovery programs and business development, serving cancer patients. Founded in 2018, it became a commercial-stage company in 2025.

bioBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.

Mana BioMana.bio is a biotech company that uses machine learning and high-throughput screening to design lipid nanoparticles for targeted delivery of nucleic acid therapeutics and vaccines. The company aims to unlock RNA-based treatments for genetic diseases with unmet medical needs.

Companies working in the same space as NunaBio - company.

Frequently asked questions

What does NunaBio - company do?: NunaBio manufactures high-complexity DNA constructs from challenging sequences up to production-scale volumes using a modular, cell-free "DNA micro-foundry" platform. It provides software-orchestrated, distributed DNA manufacturing infrastructure for producing complex DNA without process redevelopment.
Who are NunaBio - company's investors?: NunaBio - company's investors include Ascension, EMV Capital, Martlet Capital, Maven Capital Partners, Northstar Ventures.
Where is NunaBio - company headquartered?: NunaBio - company is headquartered in Newcastle upon Tyne, GB.